Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand Jeyasekharan

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioinformatics (Oxford, England)|November 30, 2019
Predicting synthetic lethal interactions using heterogeneous data sourcesHerty Liany, Anand Jeyasekharan, Vaibhav Rajan
IEEE Journal of Biomedical and Health Informatics|January 6, 2022
An Algorithm to Mine Therapeutic Motifs for Cancer From Networks of Genetic InteractionsHerty Liany, Yu Lin, Anand Jeyasekharan, et al.
Cureus|August 5, 2017
Life-threatening Bleed Secondary to Tumor Shrinkage Effectively Palliated with RadiotherapyMichelle Tseng, Wanyi Yew, Anand Jeyasekharan, et al.
Histopathology|January 4, 2024
Aggressive prostate myxoid mesenchymal neoplasm with novel CRTC1::NCOA2 fusionWan Jing Tay, Anand Jeyasekharan, Jian Yuan Goh, et al.
IEEE Journal of Biomedical and Health Informatics|January 16, 2024
ASTER: A Method to Predict Clinically Relevant Synthetic Lethal Genetic InteractionsHerty Liany, Aishwarya Jayagopal, Dachuan Huang, et al.
Discover Oncology|July 19, 2023
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirationsJason Yongsheng Chan, Nagavalli Somasundaram, Nicholas Grigoropoulos, et al.
BMJ Open Gastroenterology|August 21, 2020
Profiling of gastric cancer cell-surface markers to achieve tumour-normal discriminationJudith Toh, Michal Marek Hoppe, Teena Thakur, et al.
Discover Oncology|February 14, 2025
Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in AsiaYa Hwee Tan, Dok Hyun Yoon, Andrew J Davies, et al.
Expert Review of Hematology|October 9, 2019
Clinical impact of the cell-of-origin classification based on immunohistochemistry criteria and Lymph2Cx of diffuse large B-Cell lymphoma patients in a South-east Asian population: a single center experience and review of the literatureJoanne Lee, Susan Swee-Shan Hue, Stephanie Q Ko, et al.
Cancer Medicine|July 3, 2019
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphomaEsther Hian Li Chan, Liang Piu Koh, Joanne Lee, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioinformatics (Oxford, England)|November 30, 2019
Predicting synthetic lethal interactions using heterogeneous data sourcesHerty Liany, Anand Jeyasekharan, Vaibhav Rajan
IEEE Journal of Biomedical and Health Informatics|January 6, 2022
An Algorithm to Mine Therapeutic Motifs for Cancer From Networks of Genetic InteractionsHerty Liany, Yu Lin, Anand Jeyasekharan, et al.
Cureus|August 5, 2017
Life-threatening Bleed Secondary to Tumor Shrinkage Effectively Palliated with RadiotherapyMichelle Tseng, Wanyi Yew, Anand Jeyasekharan, et al.
Histopathology|January 4, 2024
Aggressive prostate myxoid mesenchymal neoplasm with novel CRTC1::NCOA2 fusionWan Jing Tay, Anand Jeyasekharan, Jian Yuan Goh, et al.
IEEE Journal of Biomedical and Health Informatics|January 16, 2024
ASTER: A Method to Predict Clinically Relevant Synthetic Lethal Genetic InteractionsHerty Liany, Aishwarya Jayagopal, Dachuan Huang, et al.
Discover Oncology|July 19, 2023
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirationsJason Yongsheng Chan, Nagavalli Somasundaram, Nicholas Grigoropoulos, et al.
BMJ Open Gastroenterology|August 21, 2020
Profiling of gastric cancer cell-surface markers to achieve tumour-normal discriminationJudith Toh, Michal Marek Hoppe, Teena Thakur, et al.
Discover Oncology|February 14, 2025
Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in AsiaYa Hwee Tan, Dok Hyun Yoon, Andrew J Davies, et al.
Expert Review of Hematology|October 9, 2019
Clinical impact of the cell-of-origin classification based on immunohistochemistry criteria and Lymph2Cx of diffuse large B-Cell lymphoma patients in a South-east Asian population: a single center experience and review of the literatureJoanne Lee, Susan Swee-Shan Hue, Stephanie Q Ko, et al.
Cancer Medicine|July 3, 2019
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphomaEsther Hian Li Chan, Liang Piu Koh, Joanne Lee, et al.
Pageof 2